Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1989 Apr;33(4):583–584. doi: 10.1128/aac.33.4.583

Pseudomonas cepacia susceptibility to sulbactam.

G A Jacoby 1, L Sutton 1
PMCID: PMC172485  PMID: 2729951

Abstract

For 25 of 32 Pseudomonas cepacia isolates, predominantly from sputum of adult patients, agar dilution MICs of sulbactam were 2.5 micrograms/ml, and for only one was the MIC more than 80 micrograms/ml. Susceptibility was reliably predicted by response to a commercial sulbactam-ampicillin disk.

Full text

PDF
583

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Gold R., Jin E., Levison H., Isles A., Fleming P. C. Ceftazidime alone and in combination in patients with cystic fibrosis: lack of efficacy in treatment of severe respiratory infections caused by Pseudomonas cepacia. J Antimicrob Chemother. 1983 Jul;12 (Suppl A):331–336. doi: 10.1093/jac/12.suppl_a.331. [DOI] [PubMed] [Google Scholar]
  2. Goldmann D. A., Klinger J. D. Pseudomonas cepacia: biology, mechanisms of virulence, epidemiology. J Pediatr. 1986 May;108(5 Pt 2):806–812. doi: 10.1016/s0022-3476(86)80749-1. [DOI] [PubMed] [Google Scholar]
  3. Isles A., Maclusky I., Corey M., Gold R., Prober C., Fleming P., Levison H. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J Pediatr. 1984 Feb;104(2):206–210. doi: 10.1016/s0022-3476(84)80993-2. [DOI] [PubMed] [Google Scholar]
  4. Moody M. R., Young W. M. In vitro susceptibility of Pseudomanas cepacia and Pseudomonas maltophilia to trimethoprim and trimethoprim-sulfamethoxazole. Antimicrob Agents Chemother. 1975 Jun;7(6):836–839. doi: 10.1128/aac.7.6.836. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Noriega E. R., Rubinstein E., Simberkoff M. S., Rahal J. J. Subacute and acute endocarditis due to Pseudomonas cepacia in heroin addicts. Am J Med. 1975 Jul;59(1):29–36. doi: 10.1016/0002-9343(75)90318-6. [DOI] [PubMed] [Google Scholar]
  6. Retsema J. A., English A. R., Girard A., Lynch J. E., Anderson M., Brennan L., Cimochowski C., Faiella J., Norcia W., Sawyer P. Sulbactam/ampicillin: in vitro spectrum, potency, and activity in models of acute infection. Rev Infect Dis. 1986 Nov-Dec;8 (Suppl 5):S528–S534. doi: 10.1093/clinids/8.supplement_5.s528. [DOI] [PubMed] [Google Scholar]
  7. Weinstein A. J., Moellering R. C., Jr, Hopkins C. C., Goldblatt A. Pseudomonas cepacia pneumonia. Am J Med Sci. 1973 Jun;265(6):491–494. doi: 10.1097/00000441-197306000-00008. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES